G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Vice President, Clinical Development - Inflammation

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeFoster City, CA, USANo salary listed

About the Job

Requirements

  • An M.D. or M.D./Ph.D. is required.
  • Significant pharmaceutical or biotechnology clinical development experience, including global program leadership and cross-functional governance experience.
  • Deep expertise in inflammation, immunology, rheumatology, autoimmune diseases, allergy/immunology, or related therapeutic areas.
  • Demonstrated success developing and executing clinical development strategies from early development through registration and lifecycle management.
  • Experience leading complex portfolios spanning multiple assets, indications, and development stages.
  • Proven capability managing strategic alliances, partnerships, and external collaborations.
  • Strong understanding of global regulatory requirements and experience interacting with major health authorities.
  • Track record of influencing executive-level decision-making and leading effectively through highly matrixed organizations.
  • Exceptional strategic thinking, business acumen, and portfolio management capabilities.
  • Ability to operate in a dynamic environment and drive alignment across diverse internal and external stakeholders.
  • Demonstrated ability to build, lead, and develop high-performing teams.

Responsibilities

  • Oversee Development Leads and multidisciplinary matrix teams responsible for advancing programs across Th2-mediated allergic diseases, rheumatologic diseases, and B-cell–mediated autoimmune diseases.
  • Set portfolio priorities across assets, disease areas, mechanisms of action, and indications.
  • Manage a team responsible for clinical development strategy and execution from pre-IND through late-stage development, ensuring scientific rigor, operational excellence, and regulatory alignment.
  • Lead development strategy for key partnered assets, including programs from business development and acquisition activities.
  • Serve as the senior Development representative for strategic alliances, governance committees, joint steering committees, and cross-company decision forums.
  • Build productive relationships with external collaborators, academic experts, investigators, regulatory agencies, and other stakeholders.
  • Collaborate with Research, Commercial, Corporate Development, Regulatory Affairs, Manufacturing, Medical Affairs, Clinical Operations, Biometrics, and other functions to align portfolio objectives and execution.
  • Partner with Kite and other strategic internal stakeholders, where applicable, to align development and portfolio strategies.
  • Represent Gilead externally in scientific, regulatory, and business forums related to the Inflammation portfolio.
  • Serve as a company-wide expert and thought leader in inflammation and autoimmune disease clinical development strategy.
  • Ensure development programs are executed in accordance with high scientific, quality, compliance, and ethical standards.
  • Attract, develop, mentor, and retain high-performing clinical talent.
  • Create inclusion by modeling inclusion and embedding the value of diversity in team management.
  • Develop talent by understanding employees’ skills, experience, aspirations, and potential and coaching them on current performance and future potential, including ensuring they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding them accountable, removing barriers, and connecting the team to the broader organization.

Desired Qualifications

  • 10+ years of relevant industry experience.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs